Surzebiclimab
BGB-900-102
Phase 2 small_molecule completed
Quick answer
Surzebiclimab for Locally Advanced or Metastatic Solid Tumors for Phase 1, Dose Escalation and Phase 2 Safety Lead-in is a Phase 2 program (small_molecule) at BeOne Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BeOne Medicines
- Indication
- Locally Advanced or Metastatic Solid Tumors for Phase 1, Dose Escalation and Phase 2 Safety Lead-in
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed